why choose us

First received: June 08, 2023

Clinical Trial: Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Atrial Fibrillation

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation in Patients With Paroxysmal Atrial Fibrillation: the SCORE Randomized Controlled Trial

Brief Summary: Pulmonary vein isolation (PVI) for paroxysmal atrial fibrillation (PAF) has limited success.The superior vena cava (SVC) has been identified as one of the most common non-pulmonary vein triggers for PAF.It is estimated that SVC isolation (SVCI) could improve the clinical results for patients with PAF.However, results from previous studies about SVCI remain controversial.It is possible that safety concerns for SVCI outweigh its benefits and lead to inadequate ablation.To address this issue, the introduction of a…

Read more